Permanent Supply Clause Samples

Permanent Supply. Subject to Clause L25.3 permanent teachers who are declared redundant and have not obtained alternative teaching positions by the first day of September following such declaration, will be appointed supply teachers according to the redundancy point system, under the following terms and conditions. (a) Seven full-time equivalent teachers shall be offered a position of Permanent Supply for one year only, at regular salary, pro-rated according to days worked. (b) Permanent supply positions established under Clause L25.1 which become vacant before September 15th, shall be filled that school year. (c) The Board will pay benefits according to Article L12.00. (d) Permanent Supply teachers are selected according to seniority, in the County, with no more than one (1) full-time equivalent appointed Permanent supply teacher per school. (e) Permanent Supply teachers shall be prepared to serve at schools within fifty (50) kilometres of their home school. (f) Teachers offered permanent supply teaching under the terms of this clause may decline in favour of severance pay. (g) Permanent Supply teachers shall be deemed to have the rights of a permanent teacher as they pertain to the staffing process.
View SourceView Similar (4)
Permanent Supply. 12.16.1.1 That the teacher be placed on permanent supply to a maximum of six (6) FTE currently on the permanent supply list. 12.16.1.2 In the event that no vacancy for which the teacher is qualified exists at the end of the two year period from the date when such teacher was declared redundant under 12.13.6, the teacher shall be terminated. 12.16.1.3 Any qualified teacher placed on permanent supply shall remain on the recall list. 12.16.1.4 If any qualified teacher placed on permanent supply unjustifiably refuses a teaching position, the teacher shall be terminated. The Chair of the Committee on Redundancy will first inform the teacher of the consequence of the refusal to accept any such vacancy.
View SourceView Similar (2)
Permanent Supply. .1.1. 1That the teacher be placed on permanent supply.
View Source
Permanent Supply. 16.17.1 The Board shall maintain a complement of four (4) employees for permanent supply. 16.17.2 Supply staff shall be assigned to replace staff who are absent due to illness or the granting of leaves of absence. 16.17.3 In the event that no positions are available due to illness or leaves of absence the supply staff may be assigned to any duties within the scope of the bargaining unit. 16.17.4 Supply staff shall be paid as per the Custodian I classification in accordance with Schedule "A". 16.17.5 After the first full shift of replacing an employee in a higher classification supply staff shall be paid the Schedule A rate of the classification to which they are assigned at the increment level to which the employee is entitled. 16.17.6 Each member of the supply staff will be assigned to a location as home base. In the event that a supply staff member is assigned to a location outside the City limits of Thunder Bay and the distance from the assigned home base is in excess of 20 km round trip the staff member shall be paid mileage for the km in excess of 20 km.
View Source
Permanent Supply. Subject to Clause 25.03 permanent teachers who are declared redundant and have not obtained alternative teaching positions by the first day of September following such declaration, will be appointed supply teachers according to the redundancy point system, under the following terms and conditions. (a) Maximum of seven full-time equivalent teachers, for a minimum of for one year only, at regular salary, pro-rated according to days worked. (b) If a teaching position becomes available in the County for which a supply teacher is qualified, the appointed supply teacher selected by the principal shall accept. If the teacher feels unable to accept the position, appointment as a supply teacher under Clause 25.01 is terminated. A teacher who accepts a position under this sub-section will be evaluated for competence as a first year teacher, if the teacher has not taught in this subject area in the previous five years. (c) Supply teacher positions established under Clause 25.01 which become vacant after September 15th, will not be filled that school year. (d) The Board will pay benefits according to Article XII. (e) Supply teachers are selected according to point totals, in the County, with no more than one full-time equivalent appointed supply teacher per school. (f) Supply teachers shall be prepared to serve at schools within 35 miles of their home school. (g) Teachers offered supply teaching under the terms of this clause may decline in favour of severance pay. (h) Effective September 1, 1985, permanent supply teachers appointed to positions under the terms of Clause 25.04 (Recall) shall have seniority for time spent as a permanent supply teacher. This seniority is in addition to the seniority restored under Clause 25.04 (f).
View Source
Permanent Supply. L12.16.1.1 The top six (6) teachers on the seniority list, who have been declared redundant, shall be placed as permanent supply teachers. These positions shall not count in the setting of the line, the following year. Whenever possible the teacher shall be placed into a long term occasional position for which the teacher is qualified.
View Source
Permanent Supply. 12.16.1.1 The top six (6) teachers on the seniority list, who have been declared redundant, shall be placed as permanent supply teachers. These positions shall not count in the setting of the line, the following year. Whenever possible the teacher shall be placed into a long term occasional position for which the teacher is qualified. 12.16.1.2 In the event that no vacancy for which the teacher is qualified exists at the end of the two year period from the date when such teacher was declared redundant, the teacher shall be terminated. 12.16.1.3 Any qualified teacher placed on permanent supply shall remain on the recall list. 12.16.1.4 If any qualified teacher placed on permanent supply unjustifiably refuses a teaching position, the teacher shall be terminated. 12.16.1.5 If classes are added after the permanent supply position is filled, these teachers, if qualified shall be used to fill the positions. 12.16.1.6 If teachers on permanent supply obtain a teaching position at some time during the school year, the permanent supply position shall cease to exist for that year.
View Source
Permanent Supply. 16.17.1 The Board shall maintain a complement of four (4) employees for permanent supply. 16.17.2 Supply staff shall be assigned to replace staff who are absent due to illness or the granting of leaves of absence. 16.17.3 In the event that no positions are available due to illness or leaves of absence the supply staff may be assigned to any duties within the scope of the bargaining unit. 36.1 This agreement shall continue in effect from September 1, 2008 and expiring on August 31, 2012, and shall continue automatically thereafter for further periods of twelve (12) months each, unless either party notifies the other in writing not less than thirty (30) days and not more than ninety (90) days prior to the annual expiration date of its desires to amend, modify or terminate this agreement. 36.2 In the event of such notification being given as to the amendment of this agreement, negotiations between the parties shall begin within thirty (30) days following such notification. the prior written agreement of the Union and the Board must be obtained.
View Source

Related to Permanent Supply

  • Equipment Supplies and Property Grantee shall comply with System Agency WIC Program’s equipment, supplies, and property policies.

  • Product Supply 5.1 In the event that Eisai notifies Radius of its desire to purchase bulk substance of Compound from Radius, Radius shall supply Eisai with all amount of such bulk substance of Compound, which meets specifications for the Product determined by Radius in the course of its Development activities pursuant to this Agreement, required by Eisai for commercial sales of Product in Japan With respect to Eisai clinical development activities for Product in Japan, upon Eisai’s request, Radius shall supply Eisai the bulk substance of Compound for * Confidential Treatment Requested by the Registrant. Redacted Portion Filed Separately with the Commission. the conduct of the Eisai Development activities in the amounts and at the times determined by the SC, having reference to the quantity of the bulk substance of Compound required for clinical trials in Japan. Radius shall charge Supply Price for applicable bulk substance of Compound. Radius shall ship such bulk substance of Compound, FOB point of manufacturing. 5.2 In the event that Eisai notifies Radius of its desire to purchase Semi-Product from Radius which meets specifications determined by Radius in the course of its Development activities pursuant to this Agreement, Radius shall supply Eisai with all amount of Semi-Product required by Eisai for commercial sales of Product in Japan. With respect to Eisai clinical development activities for Product in Japan, upon Eisai’s request, Radius shall supply Eisai Semi-Product for the conduct of the Eisai Development activities in the amounts and at the times determined by the SC, having reference to the quantity of Semi-Product required for clinical trials in Japan. Radius shall charge Supply Price for Semi-Product. Radius shall ship such Semi-Product, FOB point of manufacturing. 5.3 The Parties agree that they shall, in good faith, discuss, negotiate and execute necessary agreements containing mutually acceptable terms, including but not limited to, a supply agreement for either bulk substance of Compound or Semi-Product as well as a quality control agreement of either bulk substance of Compound or Semi-Product, in the event that Eisai notifies Radius as set forth in Article 5.1 or 5.2. 5.4 As manufacturer of the Product, Radius shall be responsible for: (a) the control of the quality of the Product promoted and sold under the Radius trademarks; as provided in Article 2.3; and (b) ensuring that all bulk substance of Compound or Semi-Product supplied to Eisai pursuant to this Article 5 shall be manufactured in accordance with the applicable good manufacturing practices (GMP) and shall meet the then applicable specifications for the bulk substance of Compound or Semi-Product; and Radius warrants that all bulk substance of Compound or Semi-Product supplied to Eisai pursuant to this Article 5 shall be manufactured in accordance with the applicable GMP and shall meet the then applicable specifications for the bulk substance of Compound or Semi-Product and will be free from defects in material and workmanship. Radius shall resolve any product liability issues in the Territory relating to the Product and shall resolve any product liability issues in Japan relating to the Product or the bulk substance of Compound or Semi-Product, as the case may be, supplied to Eisai pursuant to this Article 5 in the event and to the extent related to a breach of the warranty set forth in Article 5.4(b) at its own expense and subject to Article 5.5. 5.5 Radius’ obligations with respect to product liability in the Territory and Japan shall include the following responsibilities, each to be taken at Radius’ expense: (a) Radius shall report, at its expense, to appropriate authorities, in accordance with local requirements, all adverse events related to use of the Product in the Territory or Japan. Eisai shall provide to Radius, upon Radius’ request, reasonable assistance in connection with the reporting of all of adverse events, responding to safety queries and assessing safety issues, in each case, to the extent related to the Product in Japan. Adverse events shall be recorded in a single, centralized database, which shall be held and owned by Radius. Radius will provide, upon request by Eisai, any safety information in Radius’ control and reasonably required by Eisai in connection with the development and commercialization of the Product in Japan and all reasonable assistance in responding to safety queries related to the Product and in assessing safety issues related to the Product in Japan. Details of safety reporting activities relating to the Product will be addressed in a pharmacovigilance contract, which the Parties shall enter into after the Effective Date. (b) In the event that (i) Radius determines that an event, incident, or circumstance may result in the need for a recall or other removal of the Product or any lot or lots thereof from the market; (ii) any regulatory authority in the Territory threatens to remove a Product from the market; or (iii) any regulatory authority in the Territory requires distribution of a “Dear Doctor” letter or its equivalent regarding the use of Product, Radius shall promptly advise Eisai in writing, and shall provide Eisai with copies of all relevant correspondence, notices and the like. Notwithstanding anything the contrary herein, Radius shall have final authority to make all decisions relating to any recall, market withdrawal or other corrective action with respect to the Product in the Territory. After establishing SC pursuant to Article 3.5, all decisions relating to any recall, market withdrawal or other corrective action with respect to the Product shall be decided by the SC as set forth in Article 3.6; provided that in the event that the Parties take different positions with respect to recall, market withdrawal or other corrective action with respect to the Product, then Radius shall have the right to cease supplying bulk substance of Compound or Semi-Product to Eisai for Japan if, after good faith discussions with Eisai, Radius reasonably believes that that continued supply to Eisai exposes Radius to liability as a result of its decision with respect to the Territory. If Radius elects to cease supply, it will terminate supply in an orderly manner, as soon as practical and in accordance with a schedule agreed to by Eisai and Radius. In the event of a recall, market withdrawal or other corrective action with respect to the Product in Japan, and at Radius’ request, Eisai shall provide reasonable assistance to Radius, at Radius’ cost and expense, in conducting any such recall, market withdrawal or other corrective action with respect to the Product in Japan. 5.6 THE WARRANTY IN SECTION 5.4(b) IS IN LIEU OF ANY OTHER WARRANTY WITH RESPECT TO THE PRODUCT, BULK SUBSTANCE OF COMPOUND OR SEMI-PRODUCT SUPPLIED BY RADIUS HEREUNDER, WHETHER EXPRESS OR IMPLIED, WRITTEN OR ORAL (INCLUDING, WITHOUT LIMITATION, ANY WARRANTY OF MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE).

  • Third Party Suppliers If Licensee wishes to obtain the Compound, Product and/or Licensed Product from a Third Party source, Licensee shall notify Pfizer through MPP of the intended source prior to making any commitments to purchase the Compound, Product and/or Licensed Product. Pfizer will determine at its sole discretion whether and on what terms to grant a license to the intended source to produce the Compound, Product and/or Licensed Product or inform Licensee whether such license already exists.

  • ASSIGNMENT/SUB-CONTRACTING The Contractor agrees that he will not sell, assign or transfer this Agreement or any part thereof or interest therein without the prior written consent of the Owner.

  • Agreement Scope The scope of this Agreement is as prescribed in section 46 of the Act, setting out: • the health services to be provided to the State by the HSP, • the TTR in support of the health services to be provided, • the funding to be provided to the HSP for the provision of the health services, including the way in which the funding is to be provided, • the performance measures and operational targets for the provision of the health services by the HSP, • how the evaluation and review of results in relation to the performance measures and operational targets is to be carried out, • the performance data and other data to be provided by the HSP to the Department CEO, including how, and how often, the data is to be provided, and • any other matter the Department CEO considers relevant to the provision of the health services by the HSP. Where appropriate, reference will be made in this Agreement to Policy Frameworks issued by the Department CEO pursuant to Part 3, Division 2 of the Act.